Entity
  • coIMMUNE, Inc.

    Created in 2023
  • BETA

    Up & running (A)
    Existing signals show a regular activity
  • Social networks

    31 784
  • Activities

  • Technologies

  • Entity types

  • Location

    4233 Technology Dr, Durham, NC 27704, USA

    Durham

    United States of America

  • Employees

    Scale: 11-50

    Estimated: 8

  • Engaged corporates

    5
    2 3
  • Added in Motherbase

    1 year, 10 months ago
Description
  • Value proposition

    coIMMUNE is a privately held, clinical stage immune-oncology company that will redefine cancer treatment using best-in-class cellular immunotherapies. Our allogeneic CAR-CIK technology platform for liquid and solid tumors is a novel CAR therapy that promises enhanced efficacy with greatly reduced toxicity.

  • Home - Benecyte, Inc.

    Heterogeneous antigen expression and loss variants- in many cases only a minority of cells express the target antigen Antibody-dependent rejection of infused…

  • https://www.benecyte.com/
Corporate interactions BETA
Corporate TypeTweets Articles
Marriott International Marriott International
Hospitality
Other

12 Oct 2022


Maddy Keynote 2023
Maddy Keynote 2023
Trade show, IT Services and IT Consulting
Maddy Keynote 2023
Trade show, IT Services and IT Consulting
Other

24 Jan 2020


Agence Française de Développement
Agence Française de Développement
International development, Banking
Agence Française de Développement
International development, Banking
Other

20 Sep 2019


United Nations Office for Disarmament Affairs
United Nations Office for Disarmament Affairs
International development, International Affairs
United Nations Office for Disarmament Affairs
International development, International Affairs
Other

10 Nov 2022


Sanofi
Sanofi
Pharmaceutical, Pharmaceutical Manufacturing
Sanofi
Pharmaceutical, Pharmaceutical Manufacturing
Other

18 Dec 2019


Similar entities
Loading...
Loading...
Social network dynamics